Related references
Note: Only part of the references are listed.From Loops to Looks: Transcription Factors and Chromatin Organization Shaping Terminal B Cell Differentiation
Alba Azagra et al.
TRENDS IN IMMUNOLOGY (2020)
Efficacy of combined CDK9/13ET inhibition in preclinical models of MLL-rearranged acute leukemia
Hannah McCalmont et al.
BLOOD ADVANCES (2020)
Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues
Kate E. Grimm et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2019)
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions
Claus Meyer et al.
LEUKEMIA (2019)
γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia
Noemie Luong-Gardiol et al.
CANCER CELL (2019)
Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia
Linyu Yang et al.
CLINICAL CANCER RESEARCH (2019)
Germinal Centre B Cell Functions and Lymphomagenesis: Circuits Involving MYC and MicroRNAs
Marcela Cristina Robaina et al.
CELLS (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features
Denise Ragusa et al.
CANCER REPORTS (2019)
Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases
Nerea Vega-Garcia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia
Valentina Folgiero et al.
EMBO REPORTS (2018)
B Cell Receptor and CD40 Signaling Are Rewired for Synergistic Induction of the c-Myc Transcription Factor in Germinal Center B Cells
Wei Luo et al.
IMMUNITY (2018)
De novo activating mutations drive clonal evolution and enhance clonal fitness in KMT2A-rearranged leukemia
Axel Hyrenius-Wittsten et al.
NATURE COMMUNICATIONS (2018)
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies
Carsten Bahr et al.
NATURE (2018)
B-cell receptor-driven MALT1 activity regulates MYC signaling in mantle cell lymphoma
Beiying Dai et al.
BLOOD (2017)
Plasmablastic lymphoma phenotype is determined by genetic alterations in MYC and PRDM1
Santiago Montes-Moreno et al.
MODERN PATHOLOGY (2017)
Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
Kaiming Sun et al.
MOLECULAR CANCER THERAPEUTICS (2017)
MYC protein dysregulation is driven by BCR-PI3K signalling in diffuse large B-cell lymphoma
Wei-Ge Wang et al.
HISTOPATHOLOGY (2017)
Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase
Jonatan Ersching et al.
IMMUNITY (2017)
Mantle Cell Lymphoma With MYC Rearrangement A Report of 17 Patients
Zhihong Hu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Engagement of the B-cell receptor of chronic lymphocytic leukemia cells drives global and MYC-specific mRNA translation
Alison Yeomans et al.
BLOOD (2016)
Mantle cell lymphoma-a spectrum from indolent to aggressive disease
Birgitta Sander et al.
VIRCHOWS ARCHIV (2016)
Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma
Nakhle S. Saba et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia
Mindaugas Stoskus et al.
BLOOD CELLS MOLECULES AND DISEASES (2016)
Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities
Yong Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pre-BCR signaling in precursor B-cell acute lymphoblastic leukemia regulates PI3K/AKT, FOXO1 and MYC, and can be targeted by SYK inhibition
S. Kohrer et al.
LEUKEMIA (2016)
BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia
Yulin Li et al.
ONCOTARGET (2016)
Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas
Karen M. Chisholm et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia
Alejandra Sanjuan-Pla et al.
BLOOD (2015)
Self-Enforcing Feedback Activation between BCL6 and Pre-B Cell Receptor Signaling Defines a Distinct Subtype of Acute Lymphoblastic Leukemia
Huimin Geng et al.
CANCER CELL (2015)
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
Shuo-Chieh Wu et al.
CANCER CELL (2015)
Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia
Haruka Shinohara et al.
CANCER LETTERS (2015)
Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development
Jerry Pelletier et al.
CANCER RESEARCH (2015)
Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs
J. Chapman et al.
LEUKEMIA (2015)
The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
J. Eswaran et al.
LEUKEMIA (2015)
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
Philipp Rathert et al.
NATURE (2015)
Mechanisms of action of BCL6 during germinal center B cell development
Huang ChuanXin et al.
SCIENCE CHINA-LIFE SCIENCES (2015)
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma
B. Barneda-Zahonero et al.
CELL DEATH & DISEASE (2015)
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
Marie-Magdelaine Coude et al.
ONCOTARGET (2015)
CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients
Na Xu et al.
JOURNAL OF CANCER (2015)
TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations
Niklas Gebauer et al.
LEUKEMIA & LYMPHOMA (2015)
Dynamics of B cells in germinal centres
Nilushi S. De Silva et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Clinical Significance of MYC Expression and/or High-grade Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas A SWOG S9704 Correlative Study
James R. Cook et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Sphingosine Kinase 2 Promotes Acute Lymphoblastic Leukemia by Enhancing MYC Expression
Craig T. Wallington-Beddoe et al.
CANCER RESEARCH (2014)
SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells
Ling Li et al.
CELL STEM CELL (2014)
Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia
Almut Bokemeyer et al.
HAEMATOLOGICA (2014)
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Sietse M. Aukema et al.
HAEMATOLOGICA (2014)
CD798 and MYD88 mutations in diffuse Large B-cell Lymphoma
Yuil Kim et al.
HUMAN PATHOLOGY (2014)
Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells
F. Akbari Moqadam et al.
LEUKEMIA (2014)
Genetics of Follicular Lymphoma Transformation
Laura Pasqualucci et al.
CELL REPORTS (2014)
Oncogenic Mechanisms in Burkitt Lymphoma
Roland Schmitz et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop
James N. Psathas et al.
BLOOD (2013)
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia
Maurizio Mangolini et al.
BLOOD (2013)
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
Junwei Shi et al.
GENES & DEVELOPMENT (2013)
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Alexandra Valera et al.
HAEMATOLOGICA (2013)
MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia
Marek Mraz et al.
LEUKEMIA & LYMPHOMA (2013)
PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
Matthias Pfeifer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Defect of the INK4-Cdk4 Checkpoint and Myc Collaborate in Blastoid Mantle Cell Lymphoma-Like Lymphoma Formation in Mice
Christelle Vincent-Fabert et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Germinal Centers
Gabriel D. Victora et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells
Sergey Krysov et al.
BLOOD (2012)
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
Christopher J. Ott et al.
BLOOD (2012)
Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
Sandrine Sander et al.
CANCER CELL (2012)
Blockade of miR-150 Maturation by MLL-Fusion/MYC/LIN-28 Is Required for MLL-Associated Leukemia
Xi Jiang et al.
CANCER CELL (2012)
c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
Zuqin Nie et al.
CELL (2012)
B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18) (q32;q21): an aggressive disease with heterogeneous histology, germina center B-cell immunophenotype and poor outcome
Shaoying Li et al.
MODERN PATHOLOGY (2012)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
Roland Schmitz et al.
NATURE (2012)
The genetic landscape of mutations in Burkitt lymphoma
Cassandra Love et al.
NATURE GENETICS (2012)
The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry
David Dominguez-Sola et al.
NATURE IMMUNOLOGY (2012)
The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers
Dinis Pedro Calado et al.
NATURE IMMUNOLOGY (2012)
Molecular mechanisms that control the expression and activity of BcI-6 in TH1cells to regulate flexibility with a TFH-like gene profile
Kenneth J. Oestreich et al.
NATURE IMMUNOLOGY (2012)
Polycomb repressive complex 2 is required for MLL-AF9 leukemia
Tobias Neff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IGF2BP1 A post-transcriptional driver of tumor cell migration
Nadine Stoehr et al.
CELL ADHESION & MIGRATION (2012)
Pushing the limits of targeted therapy in chronic myeloid leukaemia
Thomas O'Hare et al.
NATURE REVIEWS CANCER (2012)
Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC
Rahul Nahar et al.
BLOOD (2011)
Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression
Joshua D. Schiffman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
The R(h)oads to Stat3: Stat3 activation by the Rho GTPases
Leda Raptis et al.
EXPERIMENTAL CELL RESEARCH (2011)
A Pediatric B Lineage Leukemia With Coincident MYC and MLL Translocations
Nathan D. Meeker et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
Cyclin D3 Is Selectively Required for Proliferative Expansion of Germinal Center B Cells
Matthew H. Cato et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib
ZiJie Liu et al.
LEUKEMIA RESEARCH (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
Volkhard Seitz et al.
PLOS ONE (2011)
The complex landscape of genetic alterations in mantle cell lymphoma
Cristina Royo et al.
SEMINARS IN CANCER BIOLOGY (2011)
Transformation of Follicular Lymphoma to Plasmablastic Lymphoma With c-myc Gene Rearrangement
Ihsane Ouansafi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas
Alexandra Valera et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells
Katia Basso et al.
BLOOD (2010)
B lymphoblastic leukemia with ETV6 amplification
Hyojin Chae et al.
CANCER GENETICS AND CYTOGENETICS (2010)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter
Gabriel D. Victora et al.
CELL (2010)
Requirement for cyclin D3 in germinal center formation and function
Jonathan U. Peled et al.
CELL RESEARCH (2010)
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
Christopher J. Stasik et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Emerging Roles of Deubiquitinases in Cancer-Associated Pathways
Joseph J. Sacco et al.
IUBMB LIFE (2010)
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features
Lekidelu Taddesse-Heath et al.
MODERN PATHOLOGY (2010)
Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas
Adam C. Seegmiller et al.
MODERN PATHOLOGY (2010)
Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-substrate complex
Linsey Reavie et al.
NATURE IMMUNOLOGY (2010)
The IKK2/NF-κB pathway suppresses MYC-induced lymphomagenesis
Kay Klapproth et al.
BLOOD (2009)
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
Weimin Ci et al.
BLOOD (2009)
PI3 Kinase Signals BCR-Dependent Mature B Cell Survival
Lakshmi Srinivasan et al.
CELL (2009)
Inhibition of cell differentiation A critical mechanism for MYC-mediated carcinogenesis?
Javier Leon et al.
CELL CYCLE (2009)
Rho GTPases in hematopoietic stem cell functions
Jose A. Cancelas et al.
CURRENT OPINION IN HEMATOLOGY (2009)
miR-19 is a key oncogenic component of mir-17-92
Virginie Olive et al.
GENES & DEVELOPMENT (2009)
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
Naoto Tomita et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
miR-24 Inhibits Cell Proliferation by Targeting E2F2, MYC, and Other Cell-Cycle Genes via Binding to Seedless 3′UTR MicroRNA Recognition Elements
Ashish Lal et al.
MOLECULAR CELL (2009)
Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia
Tanzina Chowdhury et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
c-Myc and eIF4F are components of a feedforward loop that links transcription and translation
Chen-Ju Lin et al.
CANCER RESEARCH (2008)
Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc Activity
Elisa Laurenti et al.
CELL STEM CELL (2008)
c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo
Chen He et al.
DEVELOPMENT (2008)
Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse
Ching-Yu Huang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations
Sandrine Sander et al.
HAEMATOLOGICA (2008)
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
Abdulwahab J. Al-Tourah et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes
Changchun Xiao et al.
NATURE IMMUNOLOGY (2008)
Myc stimulates B lymphocyte differentiation and amplifies calcium signaling
Tania Habib et al.
JOURNAL OF CELL BIOLOGY (2007)
A role for AID in chromosome translocations between c-myc and the IgH variable region
Yair Dorsett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma
Masumichi Saito et al.
CANCER CELL (2007)
Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development
Hiroyuki Tagawa et al.
CANCER SCIENCE (2007)
Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription
Dwayne A. Bisgrovet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
HEXIM1 and the control of transcription elongation: From cancer and inflammation to AIDS and cardiac hypertrophy
Anwesha Dey et al.
CELL CYCLE (2007)
Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells
Niklas Feldhahn et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Structural insight into pre-B cell receptor function
Alexander J. Bankovich et al.
SCIENCE (2007)
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas
P. Bertrand et al.
LEUKEMIA (2007)
Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms
Andrew J. Davies et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint
Tiziana Bruno et al.
CANCER CELL (2006)
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias
S. Malempati et al.
LEUKEMIA (2006)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
Michael Hummel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3
M Huang et al.
ONCOGENE (2006)
BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells
RT Phan et al.
NATURE IMMUNOLOGY (2005)
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants
MT Hemann et al.
NATURE (2005)
Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential:: A revised road map for adult blood lineage commitment
J Adolfsson et al.
CELL (2005)
Bim is a suppressor of Myc-induced mouse B cell leukemia
A Egle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
AID is required for c-myc/IgH chromosome translocations in vivo
AR Ramiro et al.
CELL (2004)
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome
I Simonitsch-Klupp et al.
LEUKEMIA (2004)
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation
M Welcker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Myc pathways provoking cell suicide and cancer
JA Nilsson et al.
ONCOGENE (2003)
Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells
M Shapiro-Shelef et al.
IMMUNITY (2003)
Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations
JA Martinez-Climent et al.
BLOOD (2003)
B-cell commitment: deciding on the players
RR Hardy
CURRENT OPINION IN IMMUNOLOGY (2003)
Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features
SY Hao et al.
MODERN PATHOLOGY (2002)
Jak2 is involved in c-Myc induction by Bcr-Abl
SH Xie et al.
ONCOGENE (2002)
c-MYC: More than just a matter of life and death
S Pelengaris et al.
NATURE REVIEWS CANCER (2002)
Bcr-Abl variants:: biological and clinical aspects
AS Advani et al.
LEUKEMIA RESEARCH (2002)
Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program
AL Shaffer et al.
IMMUNITY (2002)
Transformation of follicular lymphoma to diffuse large-cell lymphoma:: Alternative patterns with increased or decreased expression of c-myc and its regulated genes
IS Lossos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas
C Kawasaki et al.
LEUKEMIA & LYMPHOMA (2001)
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation
IM de Alboran et al.
IMMUNITY (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line
M Bemark et al.
ONCOGENE (2000)
Identification of CDK4 as a target of c-MYC
H Hermeking et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Molecular and clinical features of non-Burkitt's, diffuse large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene
T Akasaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
